Fred Alger Management’s Arcus Biosciences RCUS Stock Holding History

Fred Alger Management’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Buy	+60,494	New	+$1.5M	0.01%	325
2026 Q1	–	Sell	-44,758	Closed	-$1.07M	–	502
2025 Q4	$1.07M	Buy	+44,758	New	+$913K	﹤0.01%	356
2024 Q2	–	Sell	-73,498	Closed	-$1.39M	–	467
2024 Q1	$1.39M	Sell	73,498 -1,689	-2%	-$29.2K	0.01%	360
2023 Q4	$1.44M	Sell	75,187 -781	-1%	-$12.5K	0.01%	351
2023 Q3	$1.36M	Sell	75,968 -23	-0%	-$462	0.01%	349
2023 Q2	$1.54M	Sell	75,991 -1,920	-2%	-$36.6K	0.01%	354
2023 Q1	$1.42M	Sell	77,911 -573,601	-88%	-$11M	0.01%	368
2022 Q4	$13.5M	Buy	+651,512	New	+$17.9M	0.07%	184

Other funds holding RCUS

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Fred Alger Management's RCUS Position: Q2 2026 in Review

Fred Alger Management opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 60,494 shares worth $1.87M. The stake represents 0.01% of the portfolio and ranks #325 among its holdings. This is a return to the name: Fred Alger Management previously reported a position in RCUS as recently as Q4 2025.

Fred Alger Management first reported a position in RCUS in Q4 2022 and has held it in 8 quarters since. The position peaked at $13.5M in Q4 2022. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

Fred Alger Management held 60,494 shares of Arcus Biosciences worth $1.87M as of Q2 2026.
Arcus Biosciences was a new Fred Alger Management position in Q2 2026.
Arcus Biosciences made up 0.01% of Fred Alger Management's portfolio in Q2 2026, its #325 holding.
Fred Alger Management first reported a position in Arcus Biosciences in Q4 2022 and has held it in 8 quarters since.
Fred Alger Management's Arcus Biosciences position peaked at $13.5M in Q4 2022.
232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.